Persian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Benefits of the Use of Botox in the Treatment of Empty Nose Syndrome Syndrome

فقط کاربران ثبت نام شده می توانند مقالات را ترجمه کنند
ورود به سیستم / ثبت نام
پیوند در کلیپ بورد ذخیره می شود
وضعیتفسخ شده
حامیان مالی
Mayo Clinic

کلید واژه ها

خلاصه

Empty Nose Syndrome patients suffer from disabling physical symptoms and considerable distress. To date there is no definitive cure for these symptoms. Established treatment modalities include saline irrigation, surgical implantation of materials or simply use of cotton wads/ silicon cones to simulate the resistive action to airflow of the resected turbinates.
This study will research the effectiveness of a new treatment modality in the treatment of Empty Nose Syndrome. This novel treatment method involves the use of botulinum toxin type A (Botox).

شرح

Background:

Empty Nose Syndrome (ENS) is the term used to describe the condition resulting from over resection of nasal turbinate. Symptoms include depression, dysosmia, bleeding, discharge, crusting, dryness, dysosmia, and pain.

Treatment modalities include adjunctive comfort measures (primarily irrigation), mechanical measures (Silicon cones, cotton wads) and surgical treatment (alloderm implants, plastipore cartilage grafts etc.) We will investigate a new method of treatment for ENS. This will involve injection of botulinum toxin type A into the dilator nasalis muscle thus collapsing the internal nasal valve to provide added resistance to air flow.

Objective:

To evaluate effectiveness of botulinum toxin type A in improving overall quality of life in ENS patients.

Methods:

ENS patients in this study will receive botulinum toxin type A along with adjunctive treatment which will include several measures. First of all, patients will be given a nasal rinse bottle and will be instructed to irrigate their noses twice a day as follows:

- Irrigate the nose 250cc (about 125cc each side) to clear the mucus.

- Stop and gently clear the nose.

- Irrigate the nose 250cc (about 125cc each side) once again.

- Sit quietly for 10 minutes. No blowing.

- Do not blow the nose for 2 hours.

Patients will be asked to use sesame oil once a day to prevent drying of the nasal mucosa with further administration as needed. In addition they will advised to make certain lifestyle modifications that will include sleeping with a cool mist humidifier, drinking plenty of fluids and engaging in regular physical activity.

Before and after treatment data will be obtained in the form of a breathing test and patient questionnaires that will measure changes in physical and mental health.

تاریخ

آخرین تأیید شده: 02/29/2016
اولین ارسال: 08/07/2008
ثبت نام تخمینی ارسال شد: 08/10/2008
اولین ارسال: 08/11/2008
آخرین بروزرسانی ارسال شده: 03/17/2016
آخرین به روزرسانی ارسال شده: 04/17/2016
تاریخ اولین ارسال نتایج: 11/12/2013
تاریخ اولین ارسال نتایج QC: 12/29/2013
تاریخ ارسال اولین نتایج: 02/12/2014
تاریخ شروع مطالعه واقعی: 11/30/2008
تاریخ تخمین اولیه اولیه: 10/31/2009
تاریخ برآورد مطالعه: 10/31/2009

شرایط یا بیماری

Empty Nose Syndrome
Atrophic Rhinitis

مداخله / درمان

Drug: Botulinum Toxin Type A

فاز

فاز 1/فاز 2

گروههای بازو

بازومداخله / درمان
Experimental: Botulinum Toxin Type A
Treatment will be in the form of 10 Units of Botulinum Toxin Type A injected into the dilator nasalis muscle on each side of the nose.
Drug: Botulinum Toxin Type A
10 Units of Botulinum Toxin Type A injected into the dilator nasalis muscle on each side of the nose.

معیارهای صلاحیت

سنین واجد شرایط تحصیل 18 Years به 18 Years
جنسیت واجد شرایط مطالعهAll
داوطلبان سالم را می پذیردآره
شاخص

Inclusion Criteria:

- Any patient aged 18-65 years of age presenting with a known diagnosis of ENS who has no known allergies to Botox.

Exclusion Criteria:

- Patients younger than 18 years or older than 65 years of age.

- Patients with neuromuscular disorders or neuropathic diseases.

- Patients with infection and or swelling at the site where Botox is to be injected.

- Patients with known hypersensitivity to any ingredient in the drug formulation (botulinum toxin, human albumin)

- Patients who are or plan to become pregnant within the time period in which the study will be conducted.

- Patients who are nursing

نتیجه

اقدامات اولیه

1. Mean Score of Sino Nasal Outcome Test 22 (SNOT 22) [2 weeks after intervention, 2 months]

The SNOT 22 is a validated measure of health related quality of life in sinonasal disease. It is a 22 item questionnaire with each item assigned a score ranging from 0-5. The total score may range from 0-110 and lower scores represent better health related quality of life.

به صفحه فیس بوک ما بپیوندید

کاملترین پایگاه داده گیاهان دارویی با پشتیبانی علمی

  • به 55 زبان کار می کند
  • درمان های گیاهی با پشتوانه علم
  • شناسایی گیاهان توسط تصویر
  • نقشه GPS تعاملی - گیاهان را در مکان نشان دهید (به زودی)
  • انتشارات علمی مربوط به جستجوی خود را بخوانید
  • گیاهان دارویی را با توجه به اثرات آنها جستجو کنید
  • علایق خود را سازماندهی کنید و با تحقیقات اخبار ، آزمایشات بالینی و حق ثبت اختراع در جریان باشید

علامت یا بیماری را تایپ کنید و در مورد گیاهانی که ممکن است به شما کمک کنند ، بخوانید ، یک گیاه تایپ کنید و بیماری ها و علائمی را که در برابر آن استفاده می شود ، ببینید.
* کلیه اطلاعات براساس تحقیقات علمی منتشر شده است

Google Play badgeApp Store badge